TNF and psoriasis: Overall results revealed that TNF-alpha inhibitors elevated high-density lipoprotein levels in patients with psoriasis (WMD = 2.31; 95% CI: 0.96, 3.67; <i>P</i> = 0.001), which was supported by the results of sensitivity analyses excluding the effect of lipid-lowering drugs.